BACKGROUND: Survivors of head and neck squamous cell carcinoma (HNSCC) face excess mortality from multiple causes. METHODS: We used the population-based Surveillance, Epidemiology, and End Results (SEER) cancer registry data to evaluate the causes of death in patients with nonmetastatic HNSCC diagnosed between 1992 and 2005 who survived at least 3 years from diagnosis (long-term survivors). We used competing-risks proportional hazards regression to estimate probabilities of death from causes: HNSCC, second primary malignancy (SPM) excluding HNSCC, cardiovascular disease, and other causes. RESULTS: We identified 35,958 three-year survivors of HNSCC with a median age at diagnosis of 60 years (range = 18-100 years) and a median follow-up of 7.7 years (range = 3-18 years). There were 13,120 deaths during the study period. Death from any cause at 5 and 10 years was 15.4% (95% confidence interval [CI] = 15.0%-15.8%) and 41.0% (95% CI = 40.4%-41.6%), respectively. There were 3852 HNSCC deaths including both primary and subsequent head and neck tumors. The risk of death from HNSCC was greater in patients with nasopharynx or hypopharynx cancer and in patients with locally advanced disease. SPM was the leading cause of non-HNSCC death, and the most common sites of SPM death were lung (53%), esophagus (10%), and colorectal (5%) cancer. CONCLUSIONS: Many long-term HNSCC survivors die from cancers other than HNSCC and from noncancer causes. Routine follow-up care for HNSCC survivors should expand beyond surveillance for recurrent and new head and neck cancers.
BACKGROUND: Survivors of head and neck squamous cell carcinoma (HNSCC) face excess mortality from multiple causes. METHODS: We used the population-based Surveillance, Epidemiology, and End Results (SEER) cancer registry data to evaluate the causes of death in patients with nonmetastatic HNSCC diagnosed between 1992 and 2005 who survived at least 3 years from diagnosis (long-term survivors). We used competing-risks proportional hazards regression to estimate probabilities of death from causes: HNSCC, second primary malignancy (SPM) excluding HNSCC, cardiovascular disease, and other causes. RESULTS: We identified 35,958 three-year survivors of HNSCC with a median age at diagnosis of 60 years (range = 18-100 years) and a median follow-up of 7.7 years (range = 3-18 years). There were 13,120 deaths during the study period. Death from any cause at 5 and 10 years was 15.4% (95% confidence interval [CI] = 15.0%-15.8%) and 41.0% (95% CI = 40.4%-41.6%), respectively. There were 3852 HNSCC deaths including both primary and subsequent head and neck tumors. The risk of death from HNSCC was greater in patients with nasopharynx or hypopharynx cancer and in patients with locally advanced disease. SPM was the leading cause of non-HNSCC death, and the most common sites of SPM death were lung (53%), esophagus (10%), and colorectal (5%) cancer. CONCLUSIONS: Many long-term HNSCC survivors die from cancers other than HNSCC and from noncancer causes. Routine follow-up care for HNSCC survivors should expand beyond surveillance for recurrent and new head and neck cancers.
Authors: J Califano; P van der Riet; W Westra; H Nawroz; G Clayman; S Piantadosi; R Corio; D Lee; B Greenberg; W Koch; D Sidransky Journal: Cancer Res Date: 1996-06-01 Impact factor: 12.701
Authors: Alexandra W van den Belt-Dusebout; Janine Nuver; Ronald de Wit; Jourik A Gietema; Wim W ten Bokkel Huinink; Patrick T R Rodrigus; Erik C Schimmel; Berthe M P Aleman; Flora E van Leeuwen Journal: J Clin Oncol Date: 2006-01-20 Impact factor: 44.544
Authors: Clifton D Fuller; Samuel J Wang; Charles R Thomas; Henry T Hoffman; Randal S Weber; David I Rosenthal Journal: Cancer Date: 2007-04-01 Impact factor: 6.860
Authors: Lisa A Peterson; Emily L Bellile; Gregory T Wolf; Shama Virani; Andrew G Shuman; Jeremy M G Taylor; Laura S Rozek Journal: Head Neck Date: 2016-07-19 Impact factor: 3.147
Authors: Andrew J Leiker; William DeGraff; Rajani Choudhuri; Anastasia L Sowers; Angela Thetford; John A Cook; Carter Van Waes; James B Mitchell Journal: Clin Cancer Res Date: 2015-02-27 Impact factor: 12.531
Authors: Andrew C Birkeland; Andrew J Rosko; Steven B Chinn; Mark E Prince; Gordon H Sun; Matthew E Spector Journal: ORL J Otorhinolaryngol Relat Spec Date: 2016-02-25 Impact factor: 1.538
Authors: Thomas H Beckham; Jonathan Leeman; Chiaojung Jillian Tsai; Nadeem Riaz; Eric Sherman; Bhuvanesh Singh; Nancy Lee; Sean McBride; Daniel S Higginson Journal: Head Neck Date: 2019-01-11 Impact factor: 3.147
Authors: Etienne Dauzier; Benjamin Lacas; Pierre Blanchard; Quynh-Thu Le; Christian Simon; Gregory Wolf; François Janot; Masatoshi Horiuchi; Jeffrey S Tobias; James Moon; John Simes; Vinay Deshmane; Jean-Jacques Mazeron; Samir Mehta; Branko Zaktonik; Minoru Tamura; Elizabeth Moyal; Lisa Licitra; Catherine Fortpied; Bruce G Haffty; Maria Grazia Ghi; Vincent Gregoire; Jonathan Harris; Jean Bourhis; Anne Aupérin; Jean-Pierre Pignon Journal: Oral Oncol Date: 2019-06-15 Impact factor: 5.337
Authors: Daisuke Kawakita; Sarah Abdelaziz; Yuji Chen; Kerry Rowe; John Snyder; Alison Fraser; Ken Smith; Kimberly Herget; Vikrant Deshmukh; Michael Newman; Marcus Monroe; Mia Hashibe Journal: Cancer Date: 2019-11-13 Impact factor: 6.860
Authors: Christian C Okoye; Jessica Bucher; Curtis Tatsuoka; Sahil A Parikh; Guilherme H Oliveira; Michael K Gibson; Mitchell Machtay; Min Yao; Chad A Zender; Jennifer A Dorth Journal: Head Neck Date: 2016-12-29 Impact factor: 3.147
Authors: Helen E Dinkelspiel; Miriam Champer; June Hou; Ana Tergas; William M Burke; Yongmei Huang; Alfred I Neugut; Cande V Ananth; Dawn L Hershman; Jason D Wright Journal: Gynecol Oncol Date: 2015-06-05 Impact factor: 5.482